thromboxanes has been researched along with Cardiovascular Diseases in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (34.09) | 18.7374 |
| 1990's | 6 (13.64) | 18.2507 |
| 2000's | 14 (31.82) | 29.6817 |
| 2010's | 9 (20.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gurbel, PA; Navarese, EP; Tantry, US | 1 |
| Egom, EE | 1 |
| Bartimoccia, S; Carnevale, R; Farcomeni, A; Nocella, C; Pastori, D; Pignatelli, P; Violi, F | 1 |
| Bao, N; Chen, Q; Chen, W; Liu, H; Sun, C; Wang, X; Xu, Z; Zheng, Z; Zhou, Z | 1 |
| Dasilva, G; Medina, I | 1 |
| Davì, G; Liani, R; Santilli, F; Simeone, P | 1 |
| Dannenberg, L; Hohlfeld, T; Kelm, M; Levkau, B; Polzin, A; Sansone, R; Zeus, T | 1 |
| Finn, AV; Harari, E; Mori, H; Torii, S; Virmani, R | 1 |
| Bhatt, DL; Easton, JD; Eikelboom, JW; Fox, KA; Hamm, C; Hankey, GJ; Hu, T; Johnston, SC; Mak, KH; Montalescot, G; Steg, PG; Steinhubl, SR; Thom, J; Topol, EJ | 1 |
| Bassi, A; Calapai, G; Caputi, AP; Gregg, E; Lowe, F; Mannucci, C; McEwan, M; Morandi, S; Nunziata, A; Puntoni, R; Russo, GA | 1 |
| Cattaneo, M | 1 |
| Conroy, RM; Cox, D; Foley, D; Kenny, D; McCall, M; Peace, A; Tedesco, T | 1 |
| Patrignani, P | 1 |
| Anand, SS; Eikelboom, JW; Hankey, GJ; Tran, HA | 1 |
| Yadav, J | 1 |
| Bhatt, DL; Meadows, TA | 1 |
| Freedman, JE | 1 |
| Bednar, F; Hlavicka, J; Jedlickova, V; Osmancik, P; Paluch, Z; Vanek, T | 1 |
| Böhlig, B; Kurzmann, I; Roth, P; Scherer, B; Siess, W; Weber, PC | 1 |
| Markov, KhM | 1 |
| Borgeat, P; Caen, JP; Grange, MJ; Maclouf, J; Wautier, JL | 1 |
| Jacobsen, DC | 1 |
| FitzGerald, GA; Patrono, C; Pedersen, AK | 1 |
| de Boer, AC; Genton, E; Turpie, AG | 1 |
| Oelz, O | 1 |
| Horrobin, DF | 1 |
| Becker, P; Rosenberg, A; Terres, W | 1 |
| Buring, JE; Hennekens, CH; Lipinska, I; Ridker, PM; Tofler, GH | 1 |
| Averna, M; Barbagallo, CM; Basili, S; Caputo, F; Cefalù, AB; Davì, G; Ganci, A; Giammarresi, C; Notarbartolo, A; Sparacino, V | 1 |
| Hohlfeld, T; Przytulski, B; Schanz, A; Schrör, K; Weber, AA | 1 |
| Halushka, MK; Halushka, PV | 1 |
| Eikelboom, JW; Hirsh, J; Johnston, M; Weitz, JI; Yi, Q; Yusuf, S | 1 |
| SoRelle, R | 1 |
| Camu, F; Lauwers, MH; Vanlersberghe, C | 1 |
| Lorenz, R; Weber, PC | 1 |
| Ciabattoni, G; Davì, G; Patrono, C | 1 |
| Demers, LM; Granström, E; Kumlin, M; Nell, A; O'Grady, J; Peskar, BA; Salmon, JA; Sinzinger, H; Westlund, P | 1 |
| Jaschonek, K; Muller, CP | 1 |
| Braden, G; Fitzgerald, DJ; Fitzgerald, GA; Knapp, HR | 1 |
| Lefer, AM; Smith, JB | 1 |
| Laffi, G; Zipser, RD | 1 |
| Crona, N; Enk, L; Mattsson, LA; Samsioe, G; Silfverstolpe, G | 1 |
| Maclouf, J | 1 |
| Courillon-Mallet, A; Wautier, JL | 1 |
17 review(s) available for thromboxanes and Cardiovascular Diseases
| Article | Year |
|---|---|
Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators.
Topics: Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Diet; Dietary Fats; Fatty Acids, Omega-3; Fatty Acids, Omega-6; Humans; Inflammation; Isoprostanes; Lipid Peroxides; Lipidomics; Mass Spectrometry; Metabolic Syndrome; Obesity; Prostaglandins; Thromboxanes | 2019 |
Platelets and diabetes mellitus.
Topics: Animals; Blood Platelets; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Oxidative Stress; Platelet Aggregation Inhibitors; Thromboxanes | 2015 |
Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease.
Topics: Angina, Unstable; Aspirin; Cardiovascular Diseases; Drug Resistance; Eicosanoids; Humans; Isoprostanes; Leukotrienes; Muscle, Smooth, Vascular; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Thromboxanes | 2003 |
Aspirin resistance.
Topics: Aspirin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Resistance; Forecasting; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Thromboxanes | 2007 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine | 2007 |
[Prostanoids in the physiology and pathology of the cardiovascular system].
Topics: Adolescent; Alprostadil; Animals; Arachidonic Acids; Blood Pressure; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Hemodynamics; Humans; Hypertension; Leukotriene B4; Prostaglandin-Endoperoxide Synthases; Prostaglandins E; Prostaglandins F; Rats; Renal Circulation; SRS-A; Stress, Psychological; Thromboxanes | 1982 |
[Prostaglandins, thromboxanes and leukotrienes. Their role in cardiovascular diseases, allergic reactions and inflammation].
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Cardiovascular Diseases; Humans; Hypersensitivity; Inflammation; Leukotriene B4; Lipoxygenase; Prostaglandin-Endoperoxide Synthases; Prostaglandins; SRS-A; Thromboxanes | 1984 |
Prostaglandins and cardiovascular disease--a review.
Topics: Arachidonic Acids; Arteriosclerosis; Cardiovascular Diseases; Cerebrovascular Disorders; Coronary Disease; Epoprostenol; Extracorporeal Circulation; Fetus; Homeostasis; Humans; Prostaglandin Antagonists; Prostaglandins; Pulmonary Embolism; Shock; Thromboxanes | 1983 |
Platelet consumption in cardiovascular disease.
Topics: Angina Pectoris; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Platelets; Cardiovascular Diseases; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Heart Valve Diseases; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Rabbits; Radionuclide Imaging; Thromboembolism; Thrombosis; Thromboxanes | 1982 |
The clinical significance of arachidonic acid metabolites.
Topics: Animals; Arachidonic Acids; Cardiovascular Diseases; Diabetes Mellitus; Diet; Drug Interactions; Ductus Arteriosus, Patent; Female; Gastrointestinal Diseases; Hematologic Diseases; Humans; Hypercalcemia; Hypersensitivity; Infant, Newborn; Inflammation; Kidney Diseases; Lung Diseases; Male; Neoplasms; Pregnancy; Prostaglandin Antagonists; Prostaglandins; Reproduction; Thromboxanes | 1982 |
Prostaglandin synthetase inhibitor treatment and the regulatory role of prostaglandins on organ perfusion.
Topics: Animals; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Hemodynamics; Humans; Microcirculation; Prostaglandins; Regional Blood Flow; Thromboxanes | 1992 |
Thromboxane as diagnostic tool and therapeutic target in cardiovascular disease.
Topics: Blood Platelets; Cardiovascular Diseases; Humans; Thromboxanes | 1992 |
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors.
Topics: Animals; Cardiovascular Diseases; Humans; Risk Factors; Thromboxanes | 1992 |
Platelet and vessel associated prostacyclin and thromboxane A2/prostaglandin endoperoxide receptors.
Topics: Adenylyl Cyclases; Blood Platelets; Calcium; Cardiovascular Diseases; Cyclic AMP; Epoprostenol; Humans; Hydrolysis; Ion Channels; Muscle, Smooth, Vascular; Phosphatidylinositols; Receptors, Epoprostenol; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes | 1988 |
Fish oils in cardiovascular disease.
Topics: Arteriosclerosis; Blood Platelets; Blood Pressure; Cardiovascular Diseases; Fatty Acids, Unsaturated; Fish Oils; Humans; Lipid Peroxides; Platelet-Derived Growth Factor; Thromboxanes | 1989 |
Prostaglandins, thromboxanes and leukotrienes in clinical medicine.
Topics: Animals; Anti-Inflammatory Agents; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Digestive System; Digestive System Physiological Phenomena; Female; Humans; Immunity, Cellular; Inflammation; Kidney; Leukotriene B4; Lung; Lung Diseases; Male; Metabolic Diseases; Pregnancy; Prostaglandin Antagonists; Prostaglandins; Reproduction; SRS-A; Thromboxanes; Uterine Contraction | 1985 |
Progestogens and lipid metabolism.
Topics: Adipose Tissue; Animals; Cardiovascular Diseases; Chemical Phenomena; Chemistry; Drug Combinations; Epoprostenol; Estrogens; Fatty Acids; Female; Gonadal Steroid Hormones; Humans; Lipase; Lipid Metabolism; Lipids; Lipoproteins; Liver; Phosphatidylcholines; Phospholipids; Progestins; Thromboxanes | 1986 |
3 trial(s) available for thromboxanes and Cardiovascular Diseases
| Article | Year |
|---|---|
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular risk.
Topics: Aged; Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Internationality; Male; Middle Aged; Risk Factors; Survival Rate; Thromboxane B2; Thromboxanes | 2008 |
Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Topics: Adenosine Diphosphate; Administration, Oral; Adult; Arachidonic Acid; Aspirin; Blood Platelets; Cardiovascular Diseases; Double-Blind Method; Drug Administration Schedule; Epinephrine; Epoprostenol; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Radioimmunoassay; Risk Factors; Thromboxanes | 1996 |
[Therapeutic prospects and prostaglandins in vascular pathology].
Topics: Angina Pectoris; Anti-Inflammatory Agents; Arachidonic Acid; Arachidonic Acids; Arteritis; Aspirin; Blood Platelets; Cardiovascular Diseases; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Epoprostenol; Female; Humans; Male; Myocardial Infarction; Prostaglandins; Raynaud Disease; Thromboxanes | 1985 |
24 other study(ies) available for thromboxanes and Cardiovascular Diseases
| Article | Year |
|---|---|
Exploration of PCSK9 as a Cardiovascular Risk Factor: Is There a Link to the Platelet?
Topics: Atrial Fibrillation; Cardiovascular Diseases; Humans; Proprotein Convertase 9; Risk Factors; Thromboxanes | 2017 |
LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient.
Topics: Atrial Fibrillation; Cardiovascular Diseases; Cholesterol, LDL; Humans; Proprotein Convertase 9; Thromboxanes | 2018 |
Reply: LDL-Cholesterol and Atherosclerotic Cardiovascular Disease: Innocent Bystander or Essential Ingredient?
Topics: Atrial Fibrillation; Cardiovascular Diseases; Cholesterol, LDL; Humans; Proprotein Convertase 9; Thromboxanes | 2018 |
Perioperative urinary thromboxane metabolites and outcome of coronary artery bypass grafting: a nested case-control study.
Topics: Cardiovascular Diseases; Case-Control Studies; Cerebrovascular Disorders; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Perioperative Period; Postoperative Complications; Risk Factors; Thromboxanes | 2018 |
Antiplatelet effects of aspirin in chronic kidney disease patients.
Topics: Aged; Aged, 80 and over; Arachidonic Acid; Aspirin; Blood Platelets; Cardiovascular Diseases; Cross-Sectional Studies; Drug Resistance; Female; Glomerular Filtration Rate; Humans; Kidney; Linear Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Renal Insufficiency, Chronic; Risk Factors; Severity of Illness Index; Thromboxanes | 2016 |
Evaluating the utility of markers of thromboxane activity and oxidative stress in cardiovascular risk prediction.
Topics: Biomarkers; Cardiovascular Diseases; Humans; Oxidative Stress; Risk Factors; Thromboxanes | 2017 |
Cardiovascular biomarkers in groups of established smokers after a decade of smoking.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Disease Progression; Female; Hemoglobins; Humans; Leukocyte Count; Male; Risk Factors; Sex Factors; Smoking; Tars; Thromboxane B2; Thromboxanes; Young Adult | 2009 |
Letter by cattaneo regarding article, "incomplete inhibition of thromboxane biosynthesis by acetylsalicylic Acid: determinants and effect on cardiovascular risk".
Topics: Aged; Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Double-Blind Method; Female; Follow-Up Studies; Humans; Internationality; Male; Middle Aged; Risk Factors; Survival Rate; Thromboxane B2; Thromboxanes | 2009 |
The role of weight and enteric coating on aspirin response in cardiovascular patients.
Topics: Aged; Aspirin; Body Weight; Cardiology; Cardiovascular Diseases; Humans; Middle Aged; Patient Compliance; Serum; Tablets, Enteric-Coated; Thromboxanes; Time Factors | 2010 |
Cardiovascular aspirin--what is the ideal dose?
Topics: Aspirin; Cardiovascular Diseases; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Product Surveillance, Postmarketing; Thromboxanes | 2006 |
Heritability, platelet function, and aspirin: a link established but cause unknown.
Topics: Arachidonic Acid; Aspirin; Black or African American; Blood Platelets; Cardiovascular Diseases; Cyclooxygenase 1; Female; Genetic Heterogeneity; Genetic Predisposition to Disease; Genetic Variation; Humans; Male; Membrane Proteins; Phenotype; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Sex Characteristics; Thrombophilia; Thrombosis; Thromboxanes; White People | 2007 |
Aspirin is insufficient in inhibition of platelet aggregation and thromboxane formation early after coronary artery bypass surgery.
Topics: Aged; Aspirin; Cardiovascular Diseases; Coronary Artery Bypass; Female; Humans; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Thromboxanes | 2009 |
Platelet-membrane fatty acids, platelet aggregation, and thromboxane formation during a mackerel diet.
Topics: Animals; Arachidonic Acids; Blood Platelets; Cardiovascular Diseases; Diet; Dietary Fats; Eicosanoic Acids; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Fishes; Greenland; Humans; Inuit; Linoleic Acids; Male; Meat; Membrane Lipids; Platelet Aggregation; Thromboxanes | 1980 |
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
Topics: Animals; Biological Assay; Blood Platelets; Cardiovascular Diseases; Chromatography, Gas; Epoprostenol; Half-Life; Homeostasis; Humans; Mass Spectrometry; Prostaglandins; Radioimmunoassay; Radioisotope Dilution Technique; Thromboxane A2; Thromboxanes | 1983 |
A new concept of lifestyle-related cardiovascular disease: the importance of interactions between cholesterol, essential fatty acids, prostaglandin E1 and thromboxane A2.
Topics: Cardiovascular Diseases; Cholesterol; Collagen; Fatty Acids, Essential; Feedback; Humans; Insulin; Life Style; Melatonin; Models, Biological; Platelet Aggregation; Prostaglandins E; Thromboxane A2; Thromboxanes; Vasoconstriction | 1980 |
Changes in cardiovascular risk profile during the cessation of smoking.
Topics: Adult; Blood Pressure; Body Weight; Cardiovascular Diseases; Catecholamines; Cyclic AMP; Female; Humans; Lipids; Male; Middle Aged; Platelet Aggregation; Prospective Studies; Reproducibility of Results; Risk Factors; Smoking Cessation; Thromboxanes | 1994 |
Determinants of enhanced thromboxane biosynthesis in renal transplantation.
Topics: Adult; Antithrombin III; Cardiovascular Diseases; Cholesterol; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Peptide Hydrolases; Postoperative Period; Reference Values; Renal Dialysis; Thromboxanes; von Willebrand Factor | 2001 |
Towards a definition of aspirin resistance: a typological approach.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cardiovascular Diseases; Cerebrovascular Disorders; Drug Resistance; Humans; Platelet Aggregation Inhibitors; Reference Values; Thromboxanes | 2002 |
Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2?
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Dose-Response Relationship, Drug; Drug Resistance; Risk Factors; Thromboxane A2; Thromboxanes | 2002 |
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Canada; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Comorbidity; Cyclooxygenase Inhibitors; Death, Sudden, Cardiac; Demography; Female; Follow-Up Studies; Humans; Male; Myocardial Infarction; Odds Ratio; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Secondary Prevention; Stroke; Thromboxane B2; Thromboxanes; Vitamin E | 2002 |
Resisting aspirin.
Topics: Aspirin; Cardiovascular Diseases; Drug Resistance; Humans; Thromboxanes | 2002 |
Thromboxane in cardiovascular disease.
Topics: Blood Preservation; Cardiovascular Diseases; Freezing; Humans; Thromboxane A2; Thromboxane B2; Thromboxanes | 1990 |
Thromboxanes as mediators of cardiovascular disease states.
Topics: Cardiovascular Diseases; Humans; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxanes | 1985 |
[Metabolic pathways of arachidonic acid: prostaglandins, thromboxane and leukotrienes].
Topics: Arachidonic Acids; Cardiovascular Diseases; Cytochrome P-450 Enzyme System; Epoprostenol; Humans; Intramolecular Oxidoreductases; Isomerases; Lipoxygenase; Prostaglandin-Endoperoxide Synthases; Prostaglandins; SRS-A; Thromboxane-A Synthase; Thromboxanes | 1985 |